Novartis Baltics

Novartis Baltics Our purpose is to reimagine medicine to improve and extend people's lives. See our community guidelines: https://go.novartis.social/47E2z0k

We use innovative science and technology to address some of society's most challenging healthcare issues. Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

2025 has been a truly remarkable year for Novartis Baltics! Lithuania, Latvia and Estonia have truly shone externally – ...
18/12/2025

2025 has been a truly remarkable year for Novartis Baltics! Lithuania, Latvia and Estonia have truly shone externally – every milestone reflecting our shared purpose: reimagining medicine and improving access for patients across the Baltics.

Just a few highlights that made this year extraordinary.

🧬 Lithuania: At the Life Sciences Baltics forum, our team, together with Region Europe colleagues, advocated for the potential of radioligand therapy as a game-changer in oncology and contributed to the broader conversation on strengthening Europe’s competitiveness.

🏆 Latvia: Novartis received the Riga Business Award for healthcare innovation impact - the first time this award has been granted to a pharmaceutical company. This recognition reinforces our growing role in digital health and our commitment to enabling access to treatments for more patients.

🤝 Estonia: By closing the Baltic cycle of Swiss Healthcare Innovation Days, we put public-private partnerships centre stage and showcased the unique expertise Novartis Baltics brings as a trusted partner in advancing healthcare innovation.

These moments reflect the power of collaboration across the healthcare ecosystem. Together, we are shaping a future where patients don’t have to wait. ⏱️

💡 Development is where ideas become therapies.  It’s where we accelerate innovation, ensure patient safety, and deliver ...
10/12/2025

💡 Development is where ideas become therapies. It’s where we accelerate innovation, ensure patient safety, and deliver access to treatments that change lives ❤️.

Today, we celebrate Development Day 2025 - driving innovation for patients as Novartis teams across the globe unite to honour achievements and strengthen the connections that make our community thrive.

Our Impact in 2025
⏱️Timely Access: Delivered new registrations across the Baltics, ensuring patients receive innovative therapies without delay.
🔬 Scientific Frontiers: Advanced Radioligand Therapy and xRNA platforms, opening new possibilities for hard-to-treat diseases.
📊 Smarter Evidence: Leveraged AI-driven solutions and real-world data to accelerate evidence generation, improving speed and quality for patients worldwide.

💬 Audronė Jurkevičiūtė, Head Regulatory Affairs Baltics, shares:
"Together, we celebrate the impact of our work and the dedication of our teams. Let us continue to drive scientific progress and deliver meaningful outcomes for patients."

These efforts add to global progress - multiple approvals, pivotal studies, and evidence generation that shape clinical practice and help people live longer and better lives.

✨ Innovation and teamwork drive us forward - today, we are deeply honoured to have received the Riga Business Award in t...
03/12/2025

✨ Innovation and teamwork drive us forward - today, we are deeply honoured to have received the Riga Business Award in the Life Sciences category. 🏆 This recognition is a testament to the passion and commitment of our colleagues, whose focus on innovation and improving patient outcomes inspires us every day. We are grateful for the dedication shown in our daily work - this award is just one milestone on our ongoing journey to reimagine medicine and make a difference for patients and society.

This award follows a thorough and independent evaluation of our approach to advancing healthcare and creating a positive impact for patients, colleagues, and society. We are especially proud of:
🚀 Introducing pioneering digital health solutions that transform how care is delivered and help address unmet patient needs in previously underserved areas.
💡 Advancing the frontiers of medicine with innovative gene therapies and radioligand treatments, bringing new hope and possibilities to patients and healthcare professionals.
🤝 Fostering a diverse and inclusive workplace, where every voice is valued and well-being is a priority.
🌱 Investing in health education, sustainability, and green initiatives to support a healthier future for our communities.
💙 Creating a supportive environment for our colleagues, with a strong focus on mental health, flexibility, and personal development.

We are grateful for the trust of our partners and the support of the wider community. This recognition in Rīga motivates us to continue innovating and working together towards a healthier tomorrow.

Thank you for inspiring us. 💙

🌍✨REthics Day is more than an event – it’s a commitment to a culture of integrity. Across the Baltics, our teams came to...
01/12/2025

🌍✨REthics Day is more than an event – it’s a commitment to a culture of integrity. Across the Baltics, our teams came together to reflect, discuss, and strengthen the ethical foundation that guides every decision we make.

Through interactive sessions on real-world dilemmas we explored how integrity shapes our daily work. These conversations reminded us that ethics isn’t just policy; it’s personal.
One powerful takeaway: trust is earned continuously. Every decision should be viewed through the eyes of our patients - someone who deserves complete confidence in our intent, integrity, and values.

💬 “REthics Day highlighted that integrity and ethical decision-making are at the heart of everything we do. Coming together with colleagues from across the Baltics, I was inspired by the openness, energy, and commitment in every discussion. It’s clear that we are building a culture where doing what’s right guides us - every day, in every decision.”
Ramune Lauciuviene, Country President Baltics & Ukraine

We closed the day by making personal commitments to keep ethics at the heart of every decision. Thank you to all colleagues for turning REthics Day into a true call to action!

🌍 We’re proud that our Novartis Baltics colleagues represented Novartis at One Young World - a global summit that brings...
27/11/2025

🌍 We’re proud that our Novartis Baltics colleagues represented Novartis at One Young World - a global summit that brings together young leaders from business, civil society and government to turn purpose into action for people and planet. 💙✨

💬 “Still buzzing from the One Young World experience - four days of meaningful conversations and learning from today’s real heroes. What stayed with me most was the call for purpose‑driven leadership. Our CEO Vas spoke about choosing purpose over ego - a belief that anchors every team, decision and impact we create.” — Radvile Jankute, Customer Experience and Content Manager Baltics & Ukraine

💬 “Participating in One Young World was an honour and a chance to learn from global leaders. Leadership isn’t about titles; it’s about acting with integrity, empowering others and focusing on long‑term impact.” —Auguste Ambrazaite, Data & Insights Manager

We’re grateful to work in an environment that helps future leaders grow, connect globally and build the capabilities to deliver on our mission. 🌱

💙 Every man deserves care- body, mind, and heart. During Men’s Health Month, we’re raising awareness about prostate canc...
20/11/2025

💙 Every man deserves care- body, mind, and heart. During Men’s Health Month, we’re raising awareness about prostate cancer, testicular cancer, and mental health.

🧠 Did you know?
• Prostate cancer is the 2nd most common cancer in men - in 8 will face it.
• Testicular cancer mainly affects men 15–44, with an average diagnosis age of 33.
• Mental health matters: Over 1 billion people live with conditions, yet many men don’t seek help.

Ingrīda Cinīte, Medical Engagement Partner, Latvia: “Men’s health is not just about physical well-being, it’s about feeling strong mentally and emotionally too. It’s about taking proactive steps whether that’s a simple check-up or an honest conversation about mental health. Every action counts toward a healthier future.”

✅ What can you do today?
• Schedule regular health check-ups.
• Talk openly about mental health with friends and family.
• Support initiatives that promote early detection and prevention.

📍 Learn more and get involved:
• Global Movember: https://www.movember.com/
• Latvia: https://www.spkc.gov.lv/lv/viriesu-veselibas-celvedis
• Lithuania: https://ligoniukasa.lrv.lt/lt/veiklos-sritys/informacija-gyventojams/ligu-prevencijos-programos/prostatos-vezio-prevencija/
• Estonia: https://www.terviseportaal.ee/

💙Together, let’s strengthen men’s health awareness across the Baltic countries and beyond.



FA-11558885 11/2025

🇱🇻 Celebrating Latvia’s Strength and Spirit 🇱🇻 Today, on Latvian Independence Day, we honour the resilience and determin...
18/11/2025

🇱🇻 Celebrating Latvia’s Strength and Spirit 🇱🇻

Today, on Latvian Independence Day, we honour the resilience and determination that have safeguarded our nation’s freedom through turbulent times.

At Novartis Baltics, we believe that resilient societies are built on strong, equitable health systems. Every breakthrough in science, every partnership in care, and every step forward in access to treatment helps shape a healthier, more secure Latvia - ready to face tomorrow’s challenges with confidence. 🌍🔬

Let’s celebrate the courage, innovation, and commitment that keep Latvia thriving.
Happy Independence Day! 🎉🇱🇻

💡 At Novartis, we believe that investing in healthcare is investing in the future of our society and economy. When fundi...
14/11/2025

💡 At Novartis, we believe that investing in healthcare is investing in the future of our society and economy. When funding is targeted and evidence-based, it delivers real, measurable impact - not only for patients, but for the whole country.

Latvia’s recent experience in breast cancer care is proof: targeted investment leads to better outcomes in both health and economics. Researched published this week compared patient outcomes and system impact between those diagnosed in 2015 and 2022 - a period marked by significant improvements, including access to innovative medicines. Over three years, we tracked not just costs, but the true value these investments bring.

✨ 27% improvement in survival rates across all stages, including stage IV
✨ 129 additional lives saved
✨ 53 extra life-years gained for patients every year
✨ 30% fewer hospital days
✨ Cost-effectiveness: achieved with 4x lower per-patient investment than the WHO’s recommended minimum.

This achievement was only possible thanks to an unprecedented collaboration - public and private partners coming together under a Memorandum of Understanding: Veselības ministrija, Slimību profilakses un kontroles centrs, Nacionālais veselības dienests, Latvijas Digitālās veselības centrs, AmCham Latvia, Inovācijas Veselībā, Association of Biopharmaceutical Drug Manufacturers in Latvia, and academic partners.

The methodology developed for this project is a game-changer. It empowers decision-makers with robust, evidence-based arguments for smarter healthcare financing and can be adapted to other disease areas, helping drive data-driven decisions for a healthier, more resilient society.

Let’s keep moving forward. With these results in hand, we’re committed to ongoing engagement with healthcare stakeholders and the wider community - advocating for investment that delivers strong returns for people, health, and Latvia’s future. 💙

At Novartis Baltics, we believe that digital partnerships and collaborative innovation are essential to reimagining heal...
13/11/2025

At Novartis Baltics, we believe that digital partnerships and collaborative innovation are essential to reimagining healthcare for patients and society. By uniting diverse stakeholders, we can accelerate the adoption of data-driven solutions and deliver meaningful impact for Latvia’s healthcare system. 🌍🤝

Last week’s Partnership in Healthcare strategic workshop - organized by AmCham Latvia, Veselības ministrija, and Latvijas Digitālās veselības centrs - brought together leaders from hospitals, academia, public agencies like Nacionālais veselības dienests, and private sector innovators in HealthTech and MedTech.

🎯The workshop focused on strengthening collaboration and accelerating innovation partnerships in healthcare, aiming to outline a vision for a partnership framework and lay the foundation for a more agile, innovative, and patient-centered healthcare system.

Key outcomes:
✅ Shared values for collaboration were defined, making innovation a core, integrated value.
✅ The use of testing and sandbox environments was emphasized for safe piloting of new solutions.
✅ Concrete next steps were identified to reduce administrative burden and streamline collaboration, paving the way for more efficient and effective partnership.

Thank you to all organizers and participants for driving this important dialogue. Together, we’re shaping the future of healthcare in Latvia - one partnership at a time! 💙

🎀 As Pink October – Breast Cancer Awareness Month comes to a close, Novartis stands united in our commitment to address ...
31/10/2025

🎀 As Pink October – Breast Cancer Awareness Month comes to a close, Novartis stands united in our commitment to address breast cancer across Latvia, Lithuania, and Estonia. Shared challenges call for shared commitment, and early detection through regular screenings remains key to saving lives.

📊 Globally, 1 in 20 women will be diagnosed with breast cancer in their lifetime, and 1 woman dies every minute from the disease.

📍In the Baltics, breast cancer remains the most common cancer among women. Despite progress in screening, challenges persist:
- Late-stage diagnosis due to low screening uptake and delayed access, especially in rural areas.
- Awareness gaps among older populations and underserved regions.

This October, Novartis proudly supported Patient Advocacy Groups across the Baltics to amplify the message of early detection:

🇱🇹 Spotlighting breast cancer screening with mobile mammography services in underserved regions.
🇱🇻 Encouraging women to symbolically commit to breast health through the Pink Oath campaign.
🇪🇪 Supporting a powerful campaign to raise awareness of metastatic breast cancer through education and visibility.

💬 At Novartis, our colleagues reflect on what this means in practice:

“Innovation brings hope. Awareness drives action. Community gives strength.”
— Keit Ilau, Estonia
“In small towns, screening is still out of reach. Let’s change that.”
— Virginija Josiene, Lithuania
“The Pink Oath means standing for access, empathy, and early detection.”
— Klāvs Freidenfelds, Latvia

🙏We extend our heartfelt thanks to POLA, Pink train foundation/Rozā vilciena labdarības fonds , Eesti Vähiliit - Elujõu Liit for creating and driving such impactful activities!

Together, we turn awareness into action.


FA-11546002 2025/10

🌍 Psoriasis is more than a skin condition - it’s a serious, systemic disease affecting over 60 million people worldwide....
29/10/2025

🌍 Psoriasis is more than a skin condition - it’s a serious, systemic disease affecting over 60 million people worldwide. On October 29th, we join with the global community in marking World Psoriasis Day and support global campaign: Stop the Domino Effect.

Psoriasis can lead to joint damage and is linked to increased risks for cardiometabolic diseases and mental health disorders.

💔 People living with psoriasis are twice as likely to experience serious psychological distress. It’s time to break the stigma and advocate for comprehensive care.

📍 At Novartis Baltics, we marked the day in our Lithuanian office with an educational session and a team quiz to raise awareness and foster empathy.

We believe in integrated care that addresses both physical and mental health. Let’s work together to ensure that everyone affected by psoriasis receives the support they deserve.

🔗 Learn more about the campaign: https://www.ifpa-pso.com/global-actions-overview/world-psoriasis-day

│ FA-11545305 10/2025

22/10/2025

At Novartis, we believe that strategic investment in healthcare is not just a moral imperative, but a driver of national resilience and economic growth. The Draghi report on EU competitiveness explicitly highlights the pharmaceutical sector as one of the top three strategic sectors for the EU’s future, calling for more investment and innovation. 💡🌍

Yet the Baltic countries continue to lag behind in key health and competitiveness indicators:
• Days to medicines availability: 🇪🇺 578 | 🇱🇹 819 | 🇱🇻 642 | 🇪🇪 713
• Innovative medicines availability: 🇪🇺 80 | 🇱🇹 28 | 🇱🇻 31 | 🇪🇪 42
• Healthy life years: 🇪🇺 63.1 | 🇱🇹 60.9 | 🇱🇻 52.7 | 🇪🇪 58.1
• Preventable and treatable mortality per 100k: 🇪🇺258 | 🇱🇹493 | 🇱🇻543 | 🇪🇪393

📊A new KPMG/AmCham benchmark ranks 🇱🇹20th, 🇱🇻29th, 🇪🇪26th out of 32 EU member states and global market leaders for life sciences business climate - highlighting the need for faster approvals 🚀, stronger funding 💶, and unified national strategies 🤝.

Dita Erna Sīle, Public Affairs and External Communication Head Baltics:
“At Novartis, we believe investing in healthcare is a catalyst for resilience and growth. Now it is time for bold decisions - let’s work together: industry, government, society - to ensure every person in the Baltics has access to the care they need.”

Address

Skanstes Iela 25
Riga
LV-1013

Alerts

Be the first to know and let us send you an email when Novartis Baltics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram